| ACG Clinical Guideline: Ulcerative Colitis in Adults |
124 |
| ACG Clinical Guideline: Management of Crohn's Disease in Adults |
121 |
| NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances |
79 |
| ACG Clinical Guideline: Alcoholic Liver Disease |
74 |
| ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts |
56 |
| A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome |
41 |
| EUS-Guided Biliary Drainage Versus ERCP for the Primary Palliation of Malignant Biliary Obstruction: A Multicenter Randomized Clinical Trial |
34 |
| American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome |
33 |
| Long-Term Safety of In Utero Exposure to Anti-TNF alpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study |
31 |
| Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis |
30 |
| The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis |
29 |
| Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium |
27 |
| Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial |
27 |
| Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific |
25 |
| A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review |
25 |
| Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents |
25 |
| Continuous Anti-TNF alpha Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION) |
23 |
| Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment |
22 |
| Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Sante Cohort |
21 |
| Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study |
21 |
| Depression Is Associated With More Aggressive Inflammatory Bowel Disease |
20 |
| OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients |
20 |
| Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials |
20 |
| The Natural Course of Eosinophilic Esophagitis and Long-Term Consequences of Undiagnosed Disease in a Large Cohort |
20 |
| Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis |
20 |
| A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD) |
19 |
| Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis |
19 |
| Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease |
18 |
| Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review |
18 |
| The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries |
17 |
| Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey |
17 |
| Burden of Gastrointestinal Symptoms in the United States: Results of a Nationally Representative Survey of Over 000 Americans |
17 |
| Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn |
17 |
| Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis |
17 |
| Bifidobacterium longum 1714 (TM) Strain Modulates Brain Activity of Healthy Volunteers During Social Stress |
17 |
| Timed Barium Swallow: Diagnostic Role and Predictive Value in Untreated Achalasia, Esophagogastric Junction Outflow Obstruction, and Non-Achalasia Dysphagia |
16 |
| Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori |
16 |
| Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease |
16 |
| Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem |
16 |
| Artificial Intelligence-Assisted Gastroenterology-Promises and Pitfalls |
15 |
| Autoimmune Pancreatitis |
15 |
| Complications of Antireflux Surgery |
15 |
| Risk Scores for Predicting Advanced Colorectal Neoplasia in the Average-risk Population: A Systematic Review and Meta-analysis |
15 |
| Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm |
15 |
| How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors |
15 |
| Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders |
14 |
| Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study |
14 |
| Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose |
14 |
| Esophagogastric Junction Distensibility on Functional Lumen Imaging Probe Topography Predicts Treatment Response in Achalasia-Anatomy Matters! |
14 |
| Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials |
14 |
